Barclays
CC icon

Barclays’s Chemours CC Stock Holding History

Barclays’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-234,800
Closed -$6.17M – 4914
2024
Q1 		$6.17M Buy
+234,800
New +$6.69M ﹤0.01% 1717
2022
Q1 		– Sell
-207,100
Closed -$6.95M – 4998
2021
Q4 		$6.95M Buy
207,100
+2,700
+1% +$84.1K ﹤0.01% 1484
2021
Q3 		$5.94M Buy
204,400
+4,400
+2% +$142K ﹤0.01% 1509
2021
Q2 		$6.96M Buy
+200,000
New +$6.62M ﹤0.01% 1398
2021
Q1 		– Sell
-2,000
Closed -$50K – 4733
2020
Q4 		$50K Buy
2,000
+1,000
+100% +$23.8K ﹤0.01% 4396
2020
Q3 		$21K Hold
1,000
– – ﹤0.01% 4890
2020
Q2 		$15K Sell
1,000
-1,000
-50% -$12.6K ﹤0.01% 5256
2020
Q1 		$18K Sell
2,000
-2,800
-58% -$40.4K ﹤0.01% 5668
2019
Q4 		$87K Sell
4,800
-6,800
-59% -$113K ﹤0.01% 5538
2019
Q3 		$173K Buy
11,600
+4,400
+61% +$71.6K ﹤0.01% 5075
2019
Q2 		$173K Sell
7,200
-20,800
-74% -$613K ﹤0.01% 5248
2019
Q1 		$1.04M Sell
28,000
-11,400
-29% -$415K ﹤0.01% 3357
2018
Q4 		$1.11M Buy
39,400
+19,200
+95% +$607K ﹤0.01% 2998
2018
Q3 		$797K Buy
20,200
+400
+2% +$17.5K ﹤0.01% 3854
2018
Q2 		$879K Buy
19,800
+2,900
+17% +$144K ﹤0.01% 3425
2018
Q1 		$823K Buy
16,900
+14,000
+483% +$700K ﹤0.01% 3446
2017
Q4 		$145K Sell
2,900
-1,700
-37% -$89K ﹤0.01% 4949
2017
Q3 		$233K Buy
4,600
+800
+21% +$37.7K ﹤0.01% 4295
2017
Q2 		$144K Buy
3,800
+1,600
+73% +$63.1K ﹤0.01% 4635
2017
Q1 		$85K Sell
2,200
-1,660
-43% -$50K ﹤0.01% 5003
2016
Q4 		$85K Buy
3,860
+2,200
+133% +$45.2K ﹤0.01% 4861
2016
Q3 		$27K Hold
1,660
– – ﹤0.01% 5313
2016
Q2 		$14K Hold
1,660
– – ﹤0.01% 5414
2016
Q1 		$12K Sell
1,660
-32,540
-95% -$164K ﹤0.01% 5409
2015
Q4 		$171K Sell
34,200
-10,960
-24% -$70K ﹤0.01% 4026
2015
Q3 		$271K Buy
+45,160
New +$473K ﹤0.01% 3896

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays's CC Position: Q1 2026 in Review

Barclays reduced its Chemours (CC) stake by 86% in Q1 2026, selling an estimated $3.52M and leaving 32,956 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #2954.

Barclays first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $14.8M in Q3 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Barclays held 32,956 shares of Chemours worth $726K as of Q1 2026.
  • Barclays sold 202,000 Chemours shares in Q1 2026, an estimated $3.52M.
  • Chemours made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2954 holding.
  • Barclays first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • Barclays's Chemours position peaked at $14.8M in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.